Radiotherapy remains a mainstay in cancer treatment yet many patients obtain no benefit in disease-free survival. The microenvironment, particularly via the tumor vasculature, exerts a major influence on cancer cell survival after radiotherapy. Recent work by our groups has exploited fluorescence imaging of a live-cell reporter of DNA double strand breaks (DSBs) to follow DSB formation after irradiation and the kinetics of damage repair or persistence. Here, we will examine radiation response in xenograft tumors in mice and dissect cross-talk between cancer cells and stroma. We plan to leverage complementary approaches developed in our laboratories to examine radiation response within the tumor microenvironment and then to examine the relationship between the heterogeneity of local events and overall response of tumors. Specifically, members of our group have pioneered use of 1) fluorescent DSB reporters to track DNA damage and repair in cancer cells within tumors, 2) transgenic nude mice with fluorescent stroma or vascular cells to track angiogenesis in tumors, 3) microarray analysis that can distinguish the gene expression patterns in the cancer and stromal cells, 4) advanced approaches to PET/MRI/CT and image integration to track tumor responses to targeted radiation, and 5) in vitro and computational modeling of determinants of tumor cell oxygenation and metabolism. By integrating these tools, we anticipate pursuing a multi-scale analysis and modeling of cellular proliferation vs. arrest, factoring in intrinsic determinants of DNA damage and repair and the effects of vascular geometry and angiogenesis at the level of microenvironment. We hope to project these events over time onto tumor size and metabolism on a gross level.

Public Health Relevance

Radiation therapy is a widely used treatment for cancer, but cures a minority of patients. One hypothesis is that inadequate blood flow in tumors protects some cells from radiation. This project will use advanced imaging methods to examine how radiation affects cancer cells in experimental tumors, and how this relates to blood flow. We will then apply systems biology approaches to begin to model how cancer cells survive radiation and how we might achieve better results.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA164492-02
Application #
8337726
Study Section
Special Emphasis Panel (ZCA1-SRLB-9 (O1))
Program Officer
Couch, Jennifer A
Project Start
2011-09-23
Project End
2016-07-31
Budget Start
2012-08-01
Budget End
2013-07-31
Support Year
2
Fiscal Year
2012
Total Cost
$940,921
Indirect Cost
$235,364
Name
University of Chicago
Department
Genetics
Type
Schools of Medicine
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Uehara, Fuminari; Miwa, Shinji; Tome, Yasunori et al. (2014) Comparison of UVB and UVC effects on the DNA damage-response protein 53BP1 in human pancreatic cancer. J Cell Biochem 115:1724-8
Flor, Amy C; Williams, Jimmy H; Blaine, Kelly M et al. (2014) DNA-directed assembly of antibody-fluorophore conjugates for quantitative multiparametric flow cytometry. Chembiochem 15:267-75
Miwa, Shinji; Yano, Shuya; Hiroshima, Yukihiko et al. (2013) Imaging UVC-induced DNA damage response in models of minimal cancer. J Cell Biochem 114:2493-9
Miwa, Shinji; Yano, Shuya; Tome, Yasunori et al. (2013) Dynamic color-coded fluorescence imaging of the cell-cycle phase, mitosis, and apoptosis demonstrates how caffeine modulates cisplatinum efficacy. J Cell Biochem 114:2454-60
Balogun, Fiyinfolu O; Truman, Andrew W; Kron, Stephen J (2013) DNA resection proteins Sgs1 and Exo1 are required for G1 checkpoint activation in budding yeast. DNA Repair (Amst) 12:751-60
Miwa, Shinji; Tome, Yasunori; Yano, Shuya et al. (2013) Single cell time-lapse imaging of focus formation by the DNA damage-response protein 53BP1 after UVC irradiation of human pancreatic cancer cells. Anticancer Res 33:1373-7
Meng, Yuru; Efimova, Elena V; Hamzeh, Khaled W et al. (2012) Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine. Mol Ther 20:1046-55